216 related articles for article (PubMed ID: 9669282)
1. The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes?
Lafont A; Libby P
J Am Coll Cardiol; 1998 Jul; 32(1):283-5. PubMed ID: 9669282
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling.
Schwartz RS
Am J Cardiol; 1998 Apr; 81(7A):14E-17E. PubMed ID: 9551589
[TBL] [Abstract][Full Text] [Related]
3. [Recurrent stenosis following coronary angioplasty. Clinical, cell biological and molecular aspects].
Hombach V; Waltenberger J; Voisard R; Höher M
Z Kardiol; 1995 Jan; 84(1):5-21. PubMed ID: 7863714
[TBL] [Abstract][Full Text] [Related]
4. Mediators of restenosis.
Kagan SA; Myers SI
Surg Clin North Am; 1998 Jun; 78(3):481-500. PubMed ID: 9673658
[TBL] [Abstract][Full Text] [Related]
5. [Restenosis after coronary angioplasty: its pathogenesis and prevention].
Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B
Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786
[TBL] [Abstract][Full Text] [Related]
6. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model.
Carter AJ; Laird JR; Farb A; Kufs W; Wortham DC; Virmani R
J Am Coll Cardiol; 1994 Nov; 24(5):1398-405. PubMed ID: 7930266
[TBL] [Abstract][Full Text] [Related]
7. Rapid coronary artery disease progression and angiographic stenosis morphology.
Kaski JC
Ital Heart J; 2000 Jan; 1(1):21-5. PubMed ID: 10868918
[TBL] [Abstract][Full Text] [Related]
8. Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients.
Moreno PR; Fallon JT; Murcia AM; Leon MN; Simosa H; Fuster V; Palacios IF
J Am Coll Cardiol; 1999 Oct; 34(4):1045-9. PubMed ID: 10520788
[TBL] [Abstract][Full Text] [Related]
9. Coronary angioplasty from the perspective of atherosclerotic plaque: morphologic predictors of immediate success and restenosis.
Virmani R; Farb A; Burke AP
Am Heart J; 1994 Jan; 127(1):163-79. PubMed ID: 8273736
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of restenosis after coronary angioplasty].
Leclercq F; Grolleau R
Arch Mal Coeur Vaiss; 1996 Mar; 89(3):359-65. PubMed ID: 8734189
[TBL] [Abstract][Full Text] [Related]
11. Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes.
Zhou J; Chew M; Ravn HB; Falk E
Scand J Clin Lab Invest Suppl; 1999; 230():3-11. PubMed ID: 10389196
[TBL] [Abstract][Full Text] [Related]
12. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.
Liu MW; Roubin GS; King SB
Circulation; 1989 Jun; 79(6):1374-87. PubMed ID: 2524293
[TBL] [Abstract][Full Text] [Related]
13. A cascade model for restenosis. A special case of atherosclerosis progression.
Libby P; Schwartz D; Brogi E; Tanaka H; Clinton SK
Circulation; 1992 Dec; 86(6 Suppl):III47-52. PubMed ID: 1424051
[TBL] [Abstract][Full Text] [Related]
14. Role of inflammation and metalloproteinases in plaque disruption and thrombosis.
Shah PK
Vasc Med; 1998; 3(3):199-206. PubMed ID: 9892512
[TBL] [Abstract][Full Text] [Related]
15. Changing concepts of atherogenesis.
Libby P
J Intern Med; 2000 Mar; 247(3):349-58. PubMed ID: 10762452
[TBL] [Abstract][Full Text] [Related]
16. Ischemia: reperfusion injury and restenosis after coronary angioplasty.
Park JW; Braun P; Mertens S; Heinrich KW
Ann N Y Acad Sci; 1992 Sep; 669():215-36. PubMed ID: 1444028
[TBL] [Abstract][Full Text] [Related]
17. [Restenosis: physiopathology, treatments and prevention].
Lafont A; Durand E; Rahal S; de Oliveira M; Guérin Y; Fernandez F; Desnos M; Guérot C
Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):349-53. PubMed ID: 8561439
[TBL] [Abstract][Full Text] [Related]
18. [New methods of coronary imaging II. Intracoronary ultrasonography in clinical practice].
Sgura FA; Di Mario C
Ital Heart J Suppl; 2001 Jun; 2(6):579-92. PubMed ID: 11460831
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation.
Bonta PI; Pols TW; van Tiel CM; Vos M; Arkenbout EK; Rohlena J; Koch KT; de Maat MP; Tanck MW; de Winter RJ; Pannekoek H; Biessen EA; Bot I; de Vries CJ
Circulation; 2010 May; 121(18):2023-32. PubMed ID: 20421523
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
